ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY
OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.
Projectdetails
Introduction
Treatment decisions for many pathological conditions, including inflammatory, degenerative, autoimmune, infectious diseases, and cancer, are largely based on microscopy study of the surgically excised tissue specimens (histology).
New Paradigm
OPTIPATH provides a new paradigm for gathering objective optical tissue-dependent data, which is essential to overcoming the diagnostic challenges of inter-observer variability and limited sensitivity and specificity.
Features of OPTIPATH
OPTIPATH will offer non-destructive, label-free, real-time, 3D presentation of tissue samples. This is enabled by:
- Revolutionary nano-photonic optical metasurfaces (OMS) for simultaneous single-shot acquisition of spectral and polarimetric information.
- Adaptive OMS actuated by thin-film piezoelectric Micro-Electro-Mechanical-Systems (MEMS) for rapid Vector Vortex Beam (VVB) shaping of light.
- Rapid confocal 3D imaging.
Data Interpretation
The wealth of objective diagnostic data provided will be interpreted using Machine Learning (ML) / Deep Learning (DL), and is essential to overcome inter-observer variability in diagnosis and provide actionable insights to the clinician.
Benefits
By utilizing optical markers present in unprepared tissue, histological procedures can be dramatically sped up, offering real-time diagnosis in operation theatres and pathology departments.
Conclusion
By offering timely and accurate diagnosis, OPTIPATH will enable early diagnosis and improved prognosis of recovery.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.276.577 |
Totale projectbegroting | € 3.276.577 |
Tijdlijn
Startdatum | 1-2-2025 |
Einddatum | 31-1-2028 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- SINTEF ASpenvoerder
- SYDDANSK UNIVERSITET
- OULUN YLIOPISTO
- ASTON UNIVERSITY
- NIL TECHNOLOGY APS
- UNIVERSITETET I OSLO
- OSLO UNIVERSITETSSYKEHUS HF
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENTMULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care. | EIC Pathfinder | € 2.863.733 | 2024 | Details |
ulTRafast hOlograPHic FTIR microscopYTROPHY combines advanced microscopy techniques to enable rapid, high-resolution imaging of tumor biopsies for precise diagnosis and tailored cancer therapies, enhancing patient outcomes. | EIC Pathfinder | € 1.904.544 | 2022 | Details |
Breaking the penetration limit of microscopy – Photoswitching OptoacousticsSWOPT aims to revolutionize in vivo imaging by combining optoacoustic imaging and photoswitching to visualize individual cells deep within tissues, enhancing research in life sciences and biomedicine. | EIC Pathfinder | € 3.536.935 | 2022 | Details |
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technologyDISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI. | EIC Pathfinder | € 3.018.312 | 2022 | Details |
Hybrid endoscope for esophageal in vivo histology and histochemistryESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment. | EIC Pathfinder | € 3.046.127 | 2025 | Details |
MULTIMODE NONLINEAR FIBER BASED ENDOSCOPIC IMAGING AND TREATMENT
MULTISCOPE aims to revolutionize optical diagnostics and therapy by developing a dual-function endoscopic device for real-time optical biopsy and cold atmospheric plasma treatment in gastrointestinal care.
ulTRafast hOlograPHic FTIR microscopY
TROPHY combines advanced microscopy techniques to enable rapid, high-resolution imaging of tumor biopsies for precise diagnosis and tailored cancer therapies, enhancing patient outcomes.
Breaking the penetration limit of microscopy – Photoswitching Optoacoustics
SWOPT aims to revolutionize in vivo imaging by combining optoacoustic imaging and photoswitching to visualize individual cells deep within tissues, enhancing research in life sciences and biomedicine.
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.
Hybrid endoscope for esophageal in vivo histology and histochemistry
ESOHISTO aims to revolutionize GI cancer diagnosis through innovative endoscopic technologies that enable real-time 3D imaging of diseased tissues, enhancing early detection and treatment.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Enabling the transition to 3D digital pathology3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally. | EIC Transition | € 2.493.683 | 2025 | Details |
Optical imaging platform for high-throughput longitudinal studies of the eye in disease modelsThe OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use. | ERC Proof of... | € 150.000 | 2023 | Details |
Chemometric histopathology via coherent Raman imaging for precision medicineThe CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification. | EIC Transition | € 2.441.979 | 2022 | Details |
In vivo Immunofluorescence-Optical Coherence TomographyDevelop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease. | ERC Advanced... | € 2.500.000 | 2025 | Details |
Live imaging module for organoidsThe LiveOrg project aims to develop and disseminate a non-invasive, high-resolution imaging system for organoids to enhance quality control and therapeutic evaluation across multiple medical fields. | ERC Proof of... | € 150.000 | 2024 | Details |
Enabling the transition to 3D digital pathology
3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.
Optical imaging platform for high-throughput longitudinal studies of the eye in disease models
The OPTIMEYEZ project aims to enhance a novel multi-contrast optical imaging platform for non-invasive retinal studies, facilitating drug development in neurological diseases while reducing animal use.
Chemometric histopathology via coherent Raman imaging for precision medicine
The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.
In vivo Immunofluorescence-Optical Coherence Tomography
Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.
Live imaging module for organoids
The LiveOrg project aims to develop and disseminate a non-invasive, high-resolution imaging system for organoids to enhance quality control and therapeutic evaluation across multiple medical fields.